These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9157586)

  • 1. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
    Pajkrt D; Lerch PG; van der Poll T; Levi M; Illi M; Doran JE; Arnet B; van den Ende A; ten Cate JW; van Deventer SJ
    Thromb Haemost; 1997 Feb; 77(2):303-7. PubMed ID: 9157586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
    Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
    Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia.
    Derhaschnig U; Schweeger-Exeli I; Marsik C; Cardona F; Minuz P; Jilma B
    Platelets; 2010; 21(5):320-8. PubMed ID: 20608787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulation.
    Leitner JM; Jilma B; Mayr FB; Cardona F; Spiel AO; Firbas C; Rathgen K; Stähle H; Schühly U; Graefe-Mody EU
    Clin Pharmacol Ther; 2007 Jun; 81(6):858-66. PubMed ID: 17410124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.
    Verbon A; Meijers JC; Spek CA; Hack CE; Pribble JP; Turner T; Dekkers PE; Axtelle T; Levi M; van Deventer SJ; Reitsma PH; van der Poll T
    J Infect Dis; 2003 Jan; 187(1):55-61. PubMed ID: 12508146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin-induced mortality in bile duct-ligated rats after administration of reconstituted high-density lipoprotein.
    Sewnath ME; Levels HH; Oude Elferink R; van Noorden CJ; ten Kate FJ; van Deventer SJ; Gouma DJ
    Hepatology; 2000 Dec; 32(6):1289-99. PubMed ID: 11093736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.
    Renckens R; Weijer S; de Vos AF; Pater JM; Meijers JC; Hack CE; Levi M; van der Poll T
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):483-8. PubMed ID: 14739127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia.
    de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van der Poll T
    J Infect Dis; 2001 Jun; 183(12):1815-8. PubMed ID: 11372037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstituted high density lipoprotein (rHDL) modulates platelet activity in vitro and ex vivo.
    Lerch PG; Spycher MO; Doran JE
    Thromb Haemost; 1998 Aug; 80(2):316-20. PubMed ID: 9716159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia.
    Pajkrt D; Doran JE; Koster F; Lerch PG; Arnet B; van der Poll T; ten Cate JW; van Deventer SJ
    J Exp Med; 1996 Nov; 184(5):1601-8. PubMed ID: 8920850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstituted high-density lipoprotein reduces LPS-stimulated TNF alpha.
    Casas AT; Hubsch AP; Rogers BC; Doran JE
    J Surg Res; 1995 Nov; 59(5):544-52. PubMed ID: 7475000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colistin dampens fibrinolysis and endothelial activation during endotoxaemia. A randomised, double blind trial.
    Schoergenhofer C; Matzneller P; Mußbacher M; Schmid JA; Jilma-Stohlawetz P; Zeitlinger M; Jilma B
    Thromb Haemost; 2017 Aug; 117(9):1714-1721. PubMed ID: 28796276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects.
    Legnani C; Frascaro M; Guazzaloca G; Ludovici S; Cesarano G; Coccheri S
    Arzneimittelforschung; 1993 Feb; 43(2):119-22. PubMed ID: 8457236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
    Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
    Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium inhibits platelet activity--an infusion study in healthy volunteers.
    Ravn HB; Vissinger H; Kristensen SD; Wennmalm A; Thygesen K; Husted SE
    Thromb Haemost; 1996 Jun; 75(6):939-44. PubMed ID: 8822590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteers.
    Schoergenhofer C; Buchtele N; Gelbenegger G; Derhaschnig U; Firbas C; Kovacevic KD; Schwameis M; Wohlfarth P; Rabitsch W; Jilma B
    Sci Rep; 2019 Jul; 9(1):11136. PubMed ID: 31366975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.
    de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van Der Poll T
    Blood; 2000 Feb; 95(4):1124-9. PubMed ID: 10666180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.